pyrazinamide has been researched along with 25-deacetylrifampicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acocella, G; Conti, R; Grassi, C; Luisetti, M; Pozzi, E | 1 |
| Brear, SG; Clarke, KW; Morgan, JR | 1 |
| Kwon, SY; Lee, CT; Lee, JH; Lee, SW; Park, KU; Song, J; Um, SW; Yoon, HI | 1 |
1 trial(s) available for pyrazinamide and 25-deacetylrifampicin
| Article | Year |
|---|---|
Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Linear Models; Male; Mass Spectrometry; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 2007 |
2 other study(ies) available for pyrazinamide and 25-deacetylrifampicin
| Article | Year |
|---|---|
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study.
Topics: Absorption; Antitubercular Agents; Humans; Isoniazid; Kinetics; Male; Pyrazinamide; Rifampin; Streptomycin | 1985 |
Phenomenon of rifampicin-induced discolouration of body fluids.
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chromogenic Compounds; Drug Interactions; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1993 |